blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1978959

EP1978959 - PIPERIDINE AND PIPERAZINE DERIVATIVES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.09.2012
Database last updated on 22.08.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
M's Science Corporation
Kobe International Business Center, 5F 5-5-2, Minatojima-Minamimachi Chuo-ku
Kobe 650-0047 / JP
[2008/42]
Inventor(s)01 / SUN, Connie, L.
897 Marshall Drive
Palo Alto, CA 94303 / US
 [2008/42]
Representative(s)Goodfellow, Hugh Robin, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2008/42]Goodfellow, Hugh Robin, et al
Carpmaels & Ransford, 43-45 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date06851953.718.09.2006
[2008/42]
WO2006IB04324
Priority number, dateUS20050720064P23.09.2005         Original published format: US 720064 P
[2008/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008096189
Date:14.08.2008
Language:EN
[2008/33]
Type: A2 Application without search report 
No.:EP1978959
Date:15.10.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 14.08.2008 takes the place of the publication of the European patent application.
[2008/42]
Type: B1 Patent specification 
No.:EP1978959
Date:09.11.2011
Language:EN
[2011/45]
Search report(s)International search report - published on:US16.04.2009
(Supplementary) European search report - dispatched on:EP04.08.2009
ClassificationIPC:A61K31/47, C07D211/22, C07D211/26, C07D405/06, C07D295/13, C07D295/096, C07D317/58
[2009/36]
CPC:
A61K31/47 (EP); A61P25/00 (EP); A61P25/08 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P25/30 (EP); A61P25/32 (EP); A61P25/34 (EP);
A61P25/36 (EP); A61P43/00 (EP); A61P9/10 (EP);
C07D211/22 (EP); C07D211/26 (EP); C07D295/096 (EP);
C07D317/58 (EP); C07D405/06 (EP) (-)
Former IPC [2008/42]A61K31/47
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/42]
TitleGerman:PIPERIDIN- UND PIPERAZINDERIVATE[2008/42]
English:PIPERIDINE AND PIPERAZINE DERIVATIVES[2008/42]
French:DÉRIVÉS DE PIPÉRIDINE ET DE PIPÉRAZINE[2008/42]
Entry into regional phase23.04.2008National basic fee paid 
23.04.2008Search fee paid 
23.04.2008Designation fee(s) paid 
23.04.2008Examination fee paid 
Examination procedure23.04.2008Examination requested  [2008/42]
17.11.2009Amendment by applicant (claims and/or description)
21.12.2009Despatch of a communication from the examining division (Time limit: M04)
29.04.2010Reply to a communication from the examining division
21.05.2010Despatch of a communication from the examining division (Time limit: M04)
07.09.2010Reply to a communication from the examining division
12.10.2010Despatch of a communication from the examining division (Time limit: M04)
22.02.2011Reply to a communication from the examining division
14.04.2011Communication of intention to grant the patent
10.08.2011Fee for grant paid
10.08.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.12.2009
Opposition(s)10.08.2012No opposition filed within time limit [2012/42]
Fees paidRenewal fee
23.04.2008Renewal fee patent year 03
11.09.2009Renewal fee patent year 04
14.09.2010Renewal fee patent year 05
29.09.2011Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU18.09.2006
AT09.11.2011
CY09.11.2011
CZ09.11.2011
DK09.11.2011
EE09.11.2011
FI09.11.2011
LT09.11.2011
LV09.11.2011
RO09.11.2011
SE09.11.2011
SI09.11.2011
SK09.11.2011
TR09.11.2011
BG09.02.2012
GR10.02.2012
IS09.03.2012
PT09.03.2012
[2014/34]
Former [2014/21]AT09.11.2011
CY09.11.2011
CZ09.11.2011
DK09.11.2011
EE09.11.2011
FI09.11.2011
LT09.11.2011
LV09.11.2011
RO09.11.2011
SE09.11.2011
SI09.11.2011
SK09.11.2011
TR09.11.2011
BG09.02.2012
GR10.02.2012
IS09.03.2012
PT09.03.2012
Former [2013/29]AT09.11.2011
CY09.11.2011
CZ09.11.2011
DK09.11.2011
EE09.11.2011
FI09.11.2011
LT09.11.2011
LV09.11.2011
RO09.11.2011
SE09.11.2011
SI09.11.2011
SK09.11.2011
BG09.02.2012
GR10.02.2012
IS09.03.2012
PT09.03.2012
Former [2013/07]AT09.11.2011
CY09.11.2011
CZ09.11.2011
DK09.11.2011
EE09.11.2011
LT09.11.2011
LV09.11.2011
RO09.11.2011
SE09.11.2011
SI09.11.2011
SK09.11.2011
BG09.02.2012
GR10.02.2012
IS09.03.2012
PT09.03.2012
Former [2012/36]CY09.11.2011
CZ09.11.2011
DK09.11.2011
EE09.11.2011
LT09.11.2011
LV09.11.2011
RO09.11.2011
SE09.11.2011
SI09.11.2011
SK09.11.2011
BG09.02.2012
GR10.02.2012
IS09.03.2012
PT09.03.2012
Former [2012/35]CY09.11.2011
CZ09.11.2011
DK09.11.2011
EE09.11.2011
LT09.11.2011
LV09.11.2011
SE09.11.2011
SI09.11.2011
BG09.02.2012
GR10.02.2012
IS09.03.2012
PT09.03.2012
Former [2012/34]CY09.11.2011
CZ09.11.2011
LT09.11.2011
LV09.11.2011
SE09.11.2011
SI09.11.2011
GR10.02.2012
IS09.03.2012
PT09.03.2012
Former [2012/28]CY09.11.2011
LT09.11.2011
LV09.11.2011
SE09.11.2011
SI09.11.2011
GR10.02.2012
IS09.03.2012
PT09.03.2012
Former [2012/24]LT09.11.2011
LV09.11.2011
SE09.11.2011
SI09.11.2011
GR10.02.2012
IS09.03.2012
PT09.03.2012
Former [2012/23]LT09.11.2011
GR10.02.2012
IS09.03.2012
PT09.03.2012
Former [2012/21]LT09.11.2011
IS09.03.2012
Former [2012/20]LT09.11.2011
Documents cited:Search[Y]US5281598  (VAN BAKEL FRANCISCUS H A [NL], et al) [Y] 1-17* Examples *;
 [Y]EP0711763  (SANTEN PHARMACEUTICAL CO LTD [JP]) [Y] 1-17 * page 1; example 1; claim 1 *
International search[Y]WO9103243  (DU PONT [US]);
 [Y]US5736546  (KAWASHIMA YOICHI [JP], et al)
by applicantHU157325
 DE2125037
 US3686187
 US4219559
 EP0111864
 DE3410070
 EP0160422
 WO9202502
 WO9427967
 WO9723216
 WO9843956
 WO0124786
 WO0151469
 WO0212190
 WO03004026
 WO03062224
    - J. MED. CHEM., (2003), vol. 46, no. 13, page 2589
    - GEORGIEV ET AL., FAMATSIYA, (1997), vol. 27, no. 3, pages 23 - 28
    - BENEDETTI ET AL., J. MED. CHEM., (2002), vol. 45, no. 8, pages 1577 - 1584
    - TANG ET AL., ZHONGGUO YAOKE DAXUE XUEBAO, (2001), vol. 32, no. 2, pages 180 - 184
    - SALVINO ET AL., J. COMB. CHEM., (2003), vol. 5, no. 3, pages 260 - 266
    - ZIKOLOVA ET AL., TRUDOVE NA NAUCHNOIZSLEDOVATELSKIYA KHIMIKOFARMATSEVTICHEN INSTITUT, (1974), vol. 9, pages 105 - 13
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.